Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology
MiRXES USA works in Biotechnology, out of Singapore. Privately held, at mirxes.us. It holds one address on record, all in Singapore. It employs 1 person, on the record. It lists development, diagnostics and manufacturing among its specialties. The record links seven similar brands, most of them in Biotechnology Research.
MiRXES is a biotechnology company focused on early, actionable, and personalized diagnoses. We specialize in genomic sequencing services, microRNA technologies, and the development, manufacturing, and provision of diagnostic test kits and clinical testing services. Our mission is to enable early disease detection and provide insights for better patient care by harnessing the power of microRNA and omics to augment traditional testing. Our vision is to be the world’s leading developer and provider of accurate, actionable, and affordable microRNA-powered diagnostic tests and services.
| Countries | 1 |
|---|---|
| Primary country | SG |
All codes: SG
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
One address on record, Singapore only. Primary: 2 Tukang Innovation Grove, JTC MedTech Hub, #09-02, Singapore 618305.
None linked to this brand.
19 tags on the brand's own list, among them development, diagnostics and manufacturing.
1 profile lists MiRXES USA as a peer — 35th percentile in Biotechnology. It lists ten peers of its own. Mirxes lists it back.